Vident Investment Advisory’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Vident Investment Advisory’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,381	Closed	-$258K	–	1274
2021 Q2	$258K	Buy	+9,381	New	+$184K	0.01%	972

Vident Investment Advisory's TBIO Position: Q3 2021 in Review

Vident Investment Advisory sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 9,381 shares — an estimated $258K sold.

Vident Investment Advisory first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $258K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Vident Investment Advisory reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Vident Investment Advisory sold 9,381 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $258K.
Vident Investment Advisory first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Vident Investment Advisory's Translate Bio, Inc. Common Stock position peaked at $258K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Vident Investment Advisory's 13F filing for Q3 2021, filed 12 Nov 2021.